All BioReference articles

Business

Opko deepens diagnostics with $1.5bn lab buyout

2015-06-09T00:00:00Z

Taking over clinical diagnostics service provider BioReference Laboratories gives Opko a bigger avenue to distribute and market its diagnostic tests